• Users Online: 1425
  • Print this page
  • Email this page


 
 Table of Contents  
EDITORIAL
Year : 2022  |  Volume : 12  |  Issue : 4  |  Page : 379-380

Update on the pathophysiology and treatment of central serous chorioretinopathy


Department of Ophthalmology, Kyung Hee University Hospital, Seoul, Korea

Date of Submission10-Nov-2022
Date of Acceptance10-Nov-2022
Date of Web Publication05-Dec-2022

Correspondence Address:
Prof. Seung-Young Yu
Department of Ophthalmology, Kyung Hee University Hospital, 23, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447
Korea
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2211-5056.362603

Rights and Permissions

How to cite this article:
Yu SY. Update on the pathophysiology and treatment of central serous chorioretinopathy. Taiwan J Ophthalmol 2022;12:379-80

How to cite this URL:
Yu SY. Update on the pathophysiology and treatment of central serous chorioretinopathy. Taiwan J Ophthalmol [serial online] 2022 [cited 2023 Jan 28];12:379-80. Available from: https://www.e-tjo.org/text.asp?2022/12/4/379/362603






It is an honor to take the role of editor for a special edition of the Taiwan Journal of Ophthalmology. The special edition theme is central serous chorioretinopathy (CSC). An effort was made to cover the definition, pathophysiology, diagnosis, and even recent treatment trends of CSC. The history of CSC disease is long. CSC was first described by Albrecht von Graefe in 1866 as a disease causing recurrent serous retinal detachment, which was described as central recurrent retinitis. One hundred years later, Bennett proposed the term central serous retinopathy, and after that Gass named it idiopathic central serous choroidopathy in 1967, this is now called CSC.

The recent development of imaging technology by enhanced depth imaging optical coherence tomography, optical coherence tomography angiography, and indocyanine green angiography has broadened the understanding of the pathophysiology of CSC. It is characterized by local or general thickening of the choroid, thinning of the choriocapillaris, and hyperpermeability of dilated choroidal vessels. It is understood to cause serous detachment of the neurosensory retina and/or retinal pigment epithelium detachment at the posterior pole by the damaged barrier function of the retinal pigment epithelium caused by hyperpermeability of the choroidal blood vessels. Recently, this disease has been considered one of the types caused by a mechanism called pachychoroid spectrum disease. In addition, recent evidence of choroidal dysfunction has provided clues to understanding the pathogenesis of CSC. Spaide et al.[1],[2] proposed a new hypothesis of intervortex venous anastomosis and choroidal venous overload as the pathophysiology of CSC in 2021 and 2022.

CSC treatment is still controversial, but according to evidence from clinical trials, photodynamic therapy appears to be the most effective treatment. Because steroids are a strong risk factor for CSC, it is important to confirm whether or not steroids are being used in patients with CSC. Conventional laser photocoagulation, micropulse diode laser photocoagulation, anti‒vascular endothelial growth factor therapy, and mineralocorticoid receptor antagonist therapy have been studied as other treatment options for patients with CSC, but more strong evidence is needed.

Although there have been advances in CSC diagnosis and treatment, there is still a lack of understanding of acute and chronic CSC differentiation and progression to type 1 macular neovascularization (MNV), polypoidal choroidal vasculopathy (PCV), and late atrophic stages. We hope that this special edition of the Taiwan Journal of Ophthalmology will serve as an opportunity to broaden your understanding of CSC as well as perspective on disease and treatment.



 
  References Top

1.
Spaide RF, Ledesma-Gil G, Gemmy Cheung CM. INTERVORTEX VENOUS ANASTOMOSIS IN Pachychoroid-RELATED DISORDERS. Retina. 2021;41:997-1004.  Back to cited text no. 1
    
2.
Spaide RF, Gemmy Cheung CM, Matsumoto H, Kishi S, Boon CJF, van Dijk EHC, et al. Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res 2022;86:100973.  Back to cited text no. 2
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed880    
    Printed28    
    Emailed0    
    PDF Downloaded102    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]